Short interest in Protagonist Therapeutics Inc (NASDAQ:PTGX) increased during the last reporting period, rising from 3.61M to 3.80M. This put 6.46% of the company's publicly available shares short.

Short interest for Protagonist Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Protagonist Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 690.80K shares traded per day, it would take 5.5 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.